HEADER VIRAL PROTEIN 30-MAY-23 8SZK TITLE THE CRYO-EM STRUCTURE OF PPP2R5A/HIV-1 VIF/CBFB/ELOB/ELOC COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: ELONGIN-B; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ELOB,ELONGIN 18 KDA SUBUNIT,RNA POLYMERASE II TRANSCRIPTION COMPND 5 FACTOR SIII SUBUNIT B,SIII P18,TRANSCRIPTION ELONGATION FACTOR B COMPND 6 POLYPEPTIDE 2; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ELONGIN-C; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: ELOC, ELONGIN 15 KDA SUBUNIT, RNA POLYMERASE II COMPND 12 TRANSCRIPTION FACTOR SIII SUBUNIT C, SIII P15, TRANSCRIPTION COMPND 13 ELONGATION FACTOR B POLYPEPTIDE 1; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: CORE-BINDING FACTOR SUBUNIT BETA; COMPND 17 CHAIN: C; COMPND 18 SYNONYM: CBF-BETA,POLYOMAVIRUS ENHANCER-BINDING PROTEIN 2 BETA COMPND 19 SUBUNIT,PEA2-BETA,PEBP2-BETA,SL3-3 ENHANCER FACTOR 1 SUBUNIT BETA, COMPND 20 SL3/AKV CORE-BINDING FACTOR BETA SUBUNIT; COMPND 21 ENGINEERED: YES; COMPND 22 MOL_ID: 4; COMPND 23 MOLECULE: VIRION INFECTIVITY FACTOR; COMPND 24 CHAIN: G; COMPND 25 SYNONYM: VIF,SOR PROTEIN; COMPND 26 ENGINEERED: YES; COMPND 27 MOL_ID: 5; COMPND 28 MOLECULE: SERINE/THREONINE-PROTEIN PHOSPHATASE 2A 56 KDA REGULATORY COMPND 29 SUBUNIT ALPHA ISOFORM; COMPND 30 CHAIN: D; COMPND 31 SYNONYM: PP2A B SUBUNIT ISOFORM B'-ALPHA,PP2A B SUBUNIT ISOFORM B56- COMPND 32 ALPHA,PP2A B SUBUNIT ISOFORM PR61-ALPHA,PR61ALPHA,PP2A B SUBUNIT COMPND 33 ISOFORM R5-ALPHA; COMPND 34 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ELOB, TCEB2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: ELOC, TCEB1; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 GENE: CBFB; SOURCE 20 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 22 MOL_ID: 4; SOURCE 23 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (NEW YORK-5 SOURCE 24 ISOLATE); SOURCE 25 ORGANISM_TAXID: 11698; SOURCE 26 GENE: VIF; SOURCE 27 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 28 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 29 MOL_ID: 5; SOURCE 30 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 31 ORGANISM_COMMON: HUMAN; SOURCE 32 ORGANISM_TAXID: 9606; SOURCE 33 GENE: PPP2R5A; SOURCE 34 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 35 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HIV VIF, CUL5 E3 LIGASE, PPP2R5A, VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR Y.HU,Y.XIONG REVDAT 2 30-OCT-24 8SZK 1 JRNL REVDAT 1 05-JUN-24 8SZK 0 JRNL AUTH Y.HU,K.A.DELVIKS-FRANKENBERRY,C.WU,F.ARIZAGA,V.K.PATHAK, JRNL AUTH 2 Y.XIONG JRNL TITL STRUCTURAL INSIGHTS INTO PPP2R5A DEGRADATION BY HIV-1 VIF. JRNL REF NAT.STRUCT.MOL.BIOL. V. 31 1492 2024 JRNL REFN ESSN 1545-9985 JRNL PMID 38789685 JRNL DOI 10.1038/S41594-024-01314-6 REMARK 2 REMARK 2 RESOLUTION. 3.58 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.580 REMARK 3 NUMBER OF PARTICLES : 500511 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8SZK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-MAY-23. REMARK 100 THE DEPOSITION ID IS D_1000274872. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : PPP2R5A IN COMPLEX WITH HIV-1 REMARK 245 VIF/CBFB/ELOB/ELOC REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, G, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 80 REMARK 465 ALA A 81 REMARK 465 ASP A 82 REMARK 465 LEU A 99 REMARK 465 PRO A 100 REMARK 465 ASP A 101 REMARK 465 VAL A 102 REMARK 465 MET A 103 REMARK 465 LYS A 104 REMARK 465 PRO A 105 REMARK 465 GLN A 106 REMARK 465 ASP A 107 REMARK 465 SER A 108 REMARK 465 GLY A 109 REMARK 465 SER A 110 REMARK 465 SER A 111 REMARK 465 ALA A 112 REMARK 465 ASN A 113 REMARK 465 GLU A 114 REMARK 465 GLN A 115 REMARK 465 ALA A 116 REMARK 465 VAL A 117 REMARK 465 GLN A 118 REMARK 465 GLY B 50 REMARK 465 GLN B 51 REMARK 465 PHE B 52 REMARK 465 ALA B 53 REMARK 465 GLU B 54 REMARK 465 ASN B 55 REMARK 465 GLU B 56 REMARK 465 THR B 57 REMARK 465 CYS B 112 REMARK 465 MET C -13 REMARK 465 GLY C -12 REMARK 465 SER C -11 REMARK 465 SER C -10 REMARK 465 HIS C -9 REMARK 465 HIS C -8 REMARK 465 HIS C -7 REMARK 465 HIS C -6 REMARK 465 HIS C -5 REMARK 465 HIS C -4 REMARK 465 SER C -3 REMARK 465 GLN C -2 REMARK 465 ASP C -1 REMARK 465 PRO C 0 REMARK 465 MET C 1 REMARK 465 PRO C 2 REMARK 465 GLN C 74 REMARK 465 GLY C 75 REMARK 465 GLU C 76 REMARK 465 GLN C 77 REMARK 465 ARG C 78 REMARK 465 GLN C 79 REMARK 465 THR C 80 REMARK 465 PRO C 81 REMARK 465 SER C 82 REMARK 465 ARG C 158 REMARK 465 SER C 159 REMARK 465 HIS C 160 REMARK 465 ARG C 161 REMARK 465 GLU C 162 REMARK 465 GLU C 163 REMARK 465 MET C 164 REMARK 465 GLU C 165 REMARK 465 ALA C 166 REMARK 465 ARG C 167 REMARK 465 ARG C 168 REMARK 465 GLN C 169 REMARK 465 GLN C 170 REMARK 465 ASP C 171 REMARK 465 PRO C 172 REMARK 465 SER C 173 REMARK 465 PRO C 174 REMARK 465 GLY C 175 REMARK 465 SER C 176 REMARK 465 ASN C 177 REMARK 465 LEU C 178 REMARK 465 GLY C 179 REMARK 465 GLY C 180 REMARK 465 GLY C 181 REMARK 465 ASP C 182 REMARK 465 ASP C 183 REMARK 465 LEU C 184 REMARK 465 LYS C 185 REMARK 465 LEU C 186 REMARK 465 ARG C 187 REMARK 465 MET D 1 REMARK 465 SER D 2 REMARK 465 SER D 3 REMARK 465 SER D 4 REMARK 465 SER D 5 REMARK 465 PRO D 6 REMARK 465 PRO D 7 REMARK 465 ALA D 8 REMARK 465 GLY D 9 REMARK 465 ALA D 10 REMARK 465 ALA D 11 REMARK 465 SER D 12 REMARK 465 ALA D 13 REMARK 465 ALA D 14 REMARK 465 ILE D 15 REMARK 465 SER D 16 REMARK 465 ALA D 17 REMARK 465 SER D 18 REMARK 465 GLU D 19 REMARK 465 LYS D 20 REMARK 465 VAL D 21 REMARK 465 ASP D 22 REMARK 465 GLY D 23 REMARK 465 PHE D 24 REMARK 465 THR D 25 REMARK 465 ARG D 26 REMARK 465 LYS D 27 REMARK 465 SER D 28 REMARK 465 VAL D 29 REMARK 465 ARG D 30 REMARK 465 LYS D 31 REMARK 465 ALA D 32 REMARK 465 GLN D 33 REMARK 465 ARG D 34 REMARK 465 GLN D 35 REMARK 465 LYS D 36 REMARK 465 ARG D 37 REMARK 465 SER D 38 REMARK 465 GLN D 39 REMARK 465 GLY D 40 REMARK 465 SER D 41 REMARK 465 SER D 42 REMARK 465 GLN D 43 REMARK 465 PHE D 44 REMARK 465 ARG D 45 REMARK 465 SER D 46 REMARK 465 GLN D 47 REMARK 465 GLY D 48 REMARK 465 SER D 49 REMARK 465 GLU D 450 REMARK 465 ARG D 451 REMARK 465 GLU D 452 REMARK 465 GLU D 453 REMARK 465 LEU D 454 REMARK 465 TRP D 455 REMARK 465 LYS D 456 REMARK 465 LYS D 457 REMARK 465 LEU D 458 REMARK 465 GLU D 459 REMARK 465 GLU D 460 REMARK 465 LEU D 461 REMARK 465 LYS D 462 REMARK 465 LEU D 463 REMARK 465 LYS D 464 REMARK 465 LYS D 465 REMARK 465 ALA D 466 REMARK 465 LEU D 467 REMARK 465 GLU D 468 REMARK 465 LYS D 469 REMARK 465 GLN D 470 REMARK 465 ASN D 471 REMARK 465 SER D 472 REMARK 465 ALA D 473 REMARK 465 TYR D 474 REMARK 465 ASN D 475 REMARK 465 MET D 476 REMARK 465 HIS D 477 REMARK 465 SER D 478 REMARK 465 ILE D 479 REMARK 465 LEU D 480 REMARK 465 SER D 481 REMARK 465 ASN D 482 REMARK 465 THR D 483 REMARK 465 SER D 484 REMARK 465 ALA D 485 REMARK 465 GLU D 486 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 1 CG SD CE REMARK 470 LYS C 20 CG CD CE NZ REMARK 470 ARG C 23 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 33 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 35 CG CD NE CZ NH1 NH2 REMARK 470 GLU C 38 CG CD OE1 OE2 REMARK 470 GLU C 84 CG CD OE1 OE2 REMARK 470 GLN G 12 CG CD OE1 NE2 REMARK 470 MET G 16 CG SD CE REMARK 470 LYS G 92 CG CD CE NZ REMARK 470 LYS G 160 CG CD CE NZ REMARK 470 ASP G 172 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU D 433 N TYR D 437 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PRO A 39 CG PRO A 39 CD -0.576 REMARK 500 PRO A 39 CD PRO A 39 N 0.106 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 39 CA - N - CD ANGL. DEV. = -15.2 DEGREES REMARK 500 PRO A 39 CA - CB - CG ANGL. DEV. = -19.9 DEGREES REMARK 500 PRO A 39 N - CD - CG ANGL. DEV. = -26.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 10 -105.79 57.75 REMARK 500 THR A 23 -78.58 -81.51 REMARK 500 VAL A 24 -25.41 -148.48 REMARK 500 GLU A 41 55.21 -67.08 REMARK 500 ASP A 47 -102.07 50.89 REMARK 500 ASP A 48 -14.54 -141.80 REMARK 500 PRO A 69 38.04 -60.97 REMARK 500 GLN A 70 -11.85 -144.01 REMARK 500 ALA A 71 69.23 -161.37 REMARK 500 VAL A 75 -6.62 -140.03 REMARK 500 GLU B 64 -28.37 72.92 REMARK 500 THR B 84 -148.02 -62.47 REMARK 500 ASN B 85 -30.11 -22.43 REMARK 500 ALA B 100 -43.58 -137.89 REMARK 500 LYS C 11 5.52 -59.81 REMARK 500 LEU C 21 11.06 -142.34 REMARK 500 SER C 22 33.65 -141.28 REMARK 500 GLU C 24 82.65 59.55 REMARK 500 ARG C 33 -5.93 69.35 REMARK 500 ARG C 52 75.44 -108.33 REMARK 500 SER C 53 -171.76 -170.70 REMARK 500 ALA C 59 5.09 -64.25 REMARK 500 GLU C 91 78.80 58.19 REMARK 500 GLU C 130 -45.40 72.57 REMARK 500 ALA C 132 -44.03 -132.95 REMARK 500 GLU C 135 -75.80 -63.46 REMARK 500 ASP C 136 130.06 -174.35 REMARK 500 ARG C 156 33.18 -89.60 REMARK 500 TYR G 44 46.32 -82.74 REMARK 500 PRO G 49 41.72 -86.09 REMARK 500 HIS G 73 -12.35 82.10 REMARK 500 GLU G 76 -135.21 59.78 REMARK 500 ARG G 77 -127.56 51.34 REMARK 500 ARG G 93 -0.35 63.85 REMARK 500 TYR G 111 -140.06 -149.65 REMARK 500 PHE G 112 -175.96 -43.21 REMARK 500 ARG G 127 46.03 -89.98 REMARK 500 ILE G 128 141.37 52.40 REMARK 500 LYS G 160 -72.35 -54.43 REMARK 500 ARG G 173 -35.78 69.54 REMARK 500 GLU D 66 13.04 51.72 REMARK 500 ASN D 111 174.96 60.49 REMARK 500 ASP D 142 31.05 -96.66 REMARK 500 ASP D 174 -66.77 -94.54 REMARK 500 PHE D 175 65.65 37.04 REMARK 500 ASP D 197 4.34 -69.44 REMARK 500 GLU D 239 -166.65 -168.53 REMARK 500 GLU D 241 61.28 61.07 REMARK 500 VAL D 275 -60.75 -124.49 REMARK 500 PHE D 317 53.70 -93.75 REMARK 500 REMARK 500 THIS ENTRY HAS 53 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TRP G 70 GLY G 71 -146.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-40919 RELATED DB: EMDB REMARK 900 THE CRYO-EM STRUCTURE OF PPP2R5A/HIV-1 VIF/CBFB/ELOB/ELOC COMPLEX DBREF 8SZK A 1 118 UNP Q15370 ELOB_HUMAN 1 118 DBREF 8SZK B 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 8SZK C 1 187 UNP Q13951 PEBB_HUMAN 1 187 DBREF 8SZK G 1 176 UNP P12504 VIF_HV1N5 1 176 DBREF 8SZK D 1 486 UNP Q15172 2A5A_HUMAN 1 486 SEQADV 8SZK MET C -13 UNP Q13951 INITIATING METHIONINE SEQADV 8SZK GLY C -12 UNP Q13951 EXPRESSION TAG SEQADV 8SZK SER C -11 UNP Q13951 EXPRESSION TAG SEQADV 8SZK SER C -10 UNP Q13951 EXPRESSION TAG SEQADV 8SZK HIS C -9 UNP Q13951 EXPRESSION TAG SEQADV 8SZK HIS C -8 UNP Q13951 EXPRESSION TAG SEQADV 8SZK HIS C -7 UNP Q13951 EXPRESSION TAG SEQADV 8SZK HIS C -6 UNP Q13951 EXPRESSION TAG SEQADV 8SZK HIS C -5 UNP Q13951 EXPRESSION TAG SEQADV 8SZK HIS C -4 UNP Q13951 EXPRESSION TAG SEQADV 8SZK SER C -3 UNP Q13951 EXPRESSION TAG SEQADV 8SZK GLN C -2 UNP Q13951 EXPRESSION TAG SEQADV 8SZK ASP C -1 UNP Q13951 EXPRESSION TAG SEQADV 8SZK PRO C 0 UNP Q13951 EXPRESSION TAG SEQRES 1 A 118 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 A 118 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 A 118 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 A 118 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 A 118 ASP GLY LYS THR LEU GLY GLU CYS GLY PHE THR SER GLN SEQRES 6 A 118 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 A 118 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CYS ILE GLU SEQRES 8 A 118 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 9 A 118 PRO GLN ASP SER GLY SER SER ALA ASN GLU GLN ALA VAL SEQRES 10 A 118 GLN SEQRES 1 B 96 MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU PHE SEQRES 2 B 96 ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR ILE SEQRES 3 B 96 LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU ASN SEQRES 4 B 96 GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER HIS SEQRES 5 B 96 VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS VAL SEQRES 6 B 96 ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE PRO SEQRES 7 B 96 ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA ALA SEQRES 8 B 96 ASN PHE LEU ASP CYS SEQRES 1 C 201 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER GLN ASP SEQRES 2 C 201 PRO MET PRO ARG VAL VAL PRO ASP GLN ARG SER LYS PHE SEQRES 3 C 201 GLU ASN GLU GLU PHE PHE ARG LYS LEU SER ARG GLU CYS SEQRES 4 C 201 GLU ILE LYS TYR THR GLY PHE ARG ASP ARG PRO HIS GLU SEQRES 5 C 201 GLU ARG GLN ALA ARG PHE GLN ASN ALA CYS ARG ASP GLY SEQRES 6 C 201 ARG SER GLU ILE ALA PHE VAL ALA THR GLY THR ASN LEU SEQRES 7 C 201 SER LEU GLN PHE PHE PRO ALA SER TRP GLN GLY GLU GLN SEQRES 8 C 201 ARG GLN THR PRO SER ARG GLU TYR VAL ASP LEU GLU ARG SEQRES 9 C 201 GLU ALA GLY LYS VAL TYR LEU LYS ALA PRO MET ILE LEU SEQRES 10 C 201 ASN GLY VAL CYS VAL ILE TRP LYS GLY TRP ILE ASP LEU SEQRES 11 C 201 GLN ARG LEU ASP GLY MET GLY CYS LEU GLU PHE ASP GLU SEQRES 12 C 201 GLU ARG ALA GLN GLN GLU ASP ALA LEU ALA GLN GLN ALA SEQRES 13 C 201 PHE GLU GLU ALA ARG ARG ARG THR ARG GLU PHE GLU ASP SEQRES 14 C 201 ARG ASP ARG SER HIS ARG GLU GLU MET GLU ALA ARG ARG SEQRES 15 C 201 GLN GLN ASP PRO SER PRO GLY SER ASN LEU GLY GLY GLY SEQRES 16 C 201 ASP ASP LEU LYS LEU ARG SEQRES 1 G 176 MET GLU ASN ARG TRP GLN VAL MET ILE VAL TRP GLN VAL SEQRES 2 G 176 ASP ARG MET ARG ILE ASN THR TRP LYS ARG LEU VAL LYS SEQRES 3 G 176 HIS HIS MET TYR ILE SER ARG LYS ALA LYS ASP TRP PHE SEQRES 4 G 176 TYR ARG HIS HIS TYR GLU SER THR ASN PRO LYS ILE SER SEQRES 5 G 176 SER GLU VAL HIS ILE PRO LEU GLY ASP ALA LYS LEU VAL SEQRES 6 G 176 ILE THR THR TYR TRP GLY LEU HIS THR GLY GLU ARG ASP SEQRES 7 G 176 TRP HIS LEU GLY GLN GLY VAL SER ILE GLU TRP ARG LYS SEQRES 8 G 176 LYS ARG TYR SER THR GLN VAL ASP PRO ASP LEU ALA ASP SEQRES 9 G 176 GLN LEU ILE HIS LEU HIS TYR PHE ASP CYS PHE SER GLU SEQRES 10 G 176 SER ALA ILE ARG ASN THR ILE LEU GLY ARG ILE VAL SER SEQRES 11 G 176 PRO ARG CYS GLU TYR GLN ALA GLY HIS ASN LYS VAL GLY SEQRES 12 G 176 SER LEU GLN TYR LEU ALA LEU ALA ALA LEU ILE LYS PRO SEQRES 13 G 176 LYS GLN ILE LYS PRO PRO LEU PRO SER VAL ARG LYS LEU SEQRES 14 G 176 THR GLU ASP ARG TRP ASN LYS SEQRES 1 D 486 MET SER SER SER SER PRO PRO ALA GLY ALA ALA SER ALA SEQRES 2 D 486 ALA ILE SER ALA SER GLU LYS VAL ASP GLY PHE THR ARG SEQRES 3 D 486 LYS SER VAL ARG LYS ALA GLN ARG GLN LYS ARG SER GLN SEQRES 4 D 486 GLY SER SER GLN PHE ARG SER GLN GLY SER GLN ALA GLU SEQRES 5 D 486 LEU HIS PRO LEU PRO GLN LEU LYS ASP ALA THR SER ASN SEQRES 6 D 486 GLU GLN GLN GLU LEU PHE CYS GLN LYS LEU GLN GLN CYS SEQRES 7 D 486 CYS ILE LEU PHE ASP PHE MET ASP SER VAL SER ASP LEU SEQRES 8 D 486 LYS SER LYS GLU ILE LYS ARG ALA THR LEU ASN GLU LEU SEQRES 9 D 486 VAL GLU TYR VAL SER THR ASN ARG GLY VAL ILE VAL GLU SEQRES 10 D 486 SER ALA TYR SER ASP ILE VAL LYS MET ILE SER ALA ASN SEQRES 11 D 486 ILE PHE ARG THR LEU PRO PRO SER ASP ASN PRO ASP PHE SEQRES 12 D 486 ASP PRO GLU GLU ASP GLU PRO THR LEU GLU ALA SER TRP SEQRES 13 D 486 PRO HIS ILE GLN LEU VAL TYR GLU PHE PHE LEU ARG PHE SEQRES 14 D 486 LEU GLU SER PRO ASP PHE GLN PRO SER ILE ALA LYS ARG SEQRES 15 D 486 TYR ILE ASP GLN LYS PHE VAL GLN GLN LEU LEU GLU LEU SEQRES 16 D 486 PHE ASP SER GLU ASP PRO ARG GLU ARG ASP PHE LEU LYS SEQRES 17 D 486 THR VAL LEU HIS ARG ILE TYR GLY LYS PHE LEU GLY LEU SEQRES 18 D 486 ARG ALA PHE ILE ARG LYS GLN ILE ASN ASN ILE PHE LEU SEQRES 19 D 486 ARG PHE ILE TYR GLU THR GLU HIS PHE ASN GLY VAL ALA SEQRES 20 D 486 GLU LEU LEU GLU ILE LEU GLY SER ILE ILE ASN GLY PHE SEQRES 21 D 486 ALA LEU PRO LEU LYS ALA GLU HIS LYS GLN PHE LEU MET SEQRES 22 D 486 LYS VAL LEU ILE PRO MET HIS THR ALA LYS GLY LEU ALA SEQRES 23 D 486 LEU PHE HIS ALA GLN LEU ALA TYR CYS VAL VAL GLN PHE SEQRES 24 D 486 LEU GLU LYS ASP THR THR LEU THR GLU PRO VAL ILE ARG SEQRES 25 D 486 GLY LEU LEU LYS PHE TRP PRO LYS THR CYS SER GLN LYS SEQRES 26 D 486 GLU VAL MET PHE LEU GLY GLU ILE GLU GLU ILE LEU ASP SEQRES 27 D 486 VAL ILE GLU PRO THR GLN PHE LYS LYS ILE GLU GLU PRO SEQRES 28 D 486 LEU PHE LYS GLN ILE SER LYS CYS VAL SER SER SER HIS SEQRES 29 D 486 PHE GLN VAL ALA GLU ARG ALA LEU TYR PHE TRP ASN ASN SEQRES 30 D 486 GLU TYR ILE LEU SER LEU ILE GLU GLU ASN ILE ASP LYS SEQRES 31 D 486 ILE LEU PRO ILE MET PHE ALA SER LEU TYR LYS ILE SER SEQRES 32 D 486 LYS GLU HIS TRP ASN PRO THR ILE VAL ALA LEU VAL TYR SEQRES 33 D 486 ASN VAL LEU LYS THR LEU MET GLU MET ASN GLY LYS LEU SEQRES 34 D 486 PHE ASP ASP LEU THR SER SER TYR LYS ALA GLU ARG GLN SEQRES 35 D 486 ARG GLU LYS LYS LYS GLU LEU GLU ARG GLU GLU LEU TRP SEQRES 36 D 486 LYS LYS LEU GLU GLU LEU LYS LEU LYS LYS ALA LEU GLU SEQRES 37 D 486 LYS GLN ASN SER ALA TYR ASN MET HIS SER ILE LEU SER SEQRES 38 D 486 ASN THR SER ALA GLU HELIX 1 AA1 VAL A 24 LYS A 36 1 13 HELIX 2 AA2 THR A 56 GLY A 61 1 6 HELIX 3 AA3 ARG B 33 LEU B 37 1 5 HELIX 4 AA4 SER B 39 SER B 47 1 9 HELIX 5 AA5 PRO B 66 TYR B 83 1 18 HELIX 6 AA6 ALA B 100 ASP B 111 1 12 HELIX 7 AA7 VAL C 4 LYS C 11 1 8 HELIX 8 AA8 GLU C 15 LYS C 20 1 6 HELIX 9 AA9 PRO C 36 ASP C 50 1 15 HELIX 10 AB1 ASP C 136 ARG C 149 1 14 HELIX 11 AB2 ASP G 14 ILE G 31 1 18 HELIX 12 AB3 ASP G 99 HIS G 108 1 10 HELIX 13 AB4 LEU G 109 TYR G 111 5 3 HELIX 14 AB5 SER G 118 GLY G 126 1 9 HELIX 15 AB6 TYR G 135 HIS G 139 5 5 HELIX 16 AB7 SER G 144 ILE G 154 1 11 HELIX 17 AB8 SER G 165 THR G 170 1 6 HELIX 18 AB9 GLU D 66 CYS D 78 1 13 HELIX 19 AC1 LYS D 92 THR D 110 1 19 HELIX 20 AC2 VAL D 116 SER D 118 5 3 HELIX 21 AC3 ALA D 119 PHE D 132 1 14 HELIX 22 AC4 SER D 155 GLU D 171 1 17 HELIX 23 AC5 GLN D 176 ILE D 184 1 9 HELIX 24 AC6 ASP D 185 LEU D 195 1 11 HELIX 25 AC7 PHE D 196 SER D 198 5 3 HELIX 26 AC8 ASP D 200 PHE D 218 1 19 HELIX 27 AC9 LEU D 221 TYR D 238 1 18 HELIX 28 AD1 GLY D 245 ASN D 258 1 14 HELIX 29 AD2 LYS D 265 VAL D 275 1 11 HELIX 30 AD3 LEU D 276 ALA D 282 5 7 HELIX 31 AD4 GLY D 284 GLU D 301 1 18 HELIX 32 AD5 ASP D 303 THR D 305 5 3 HELIX 33 AD6 LEU D 306 PHE D 317 1 12 HELIX 34 AD7 CYS D 322 LEU D 337 1 16 HELIX 35 AD8 GLU D 341 LYS D 346 1 6 HELIX 36 AD9 ILE D 348 VAL D 360 1 13 HELIX 37 AE1 HIS D 364 TYR D 373 1 10 HELIX 38 AE2 PHE D 374 ASN D 377 5 4 HELIX 39 AE3 GLU D 378 ASN D 387 1 10 HELIX 40 AE4 ASN D 387 ILE D 402 1 16 HELIX 41 AE5 SER D 403 GLU D 405 5 3 HELIX 42 AE6 ASN D 408 MET D 423 1 16 HELIX 43 AE7 ASN D 426 LEU D 449 1 24 SHEET 1 AA1 3 THR A 12 ASP A 17 0 SHEET 2 AA1 3 PHE A 4 ARG A 9 -1 N ARG A 9 O THR A 12 SHEET 3 AA1 3 ALA A 73 THR A 74 1 O ALA A 73 N MET A 6 SHEET 1 AA2 3 GLU B 28 LYS B 32 0 SHEET 2 AA2 3 TYR B 18 SER B 23 -1 N LEU B 21 O PHE B 29 SHEET 3 AA2 3 GLU B 59 PHE B 62 1 O PHE B 62 N ILE B 22 SHEET 1 AA312 TYR C 85 ASP C 87 0 SHEET 2 AA312 LYS C 94 LEU C 103 -1 O TYR C 96 N ASP C 87 SHEET 3 AA312 VAL C 106 ASP C 115 -1 O TRP C 110 N ALA C 99 SHEET 4 AA312 ASP C 120 PHE C 127 -1 O GLU C 126 N ILE C 109 SHEET 5 AA312 CYS C 25 TYR C 29 -1 N ILE C 27 O GLY C 121 SHEET 6 AA312 ILE C 55 VAL C 58 -1 O VAL C 58 N LYS C 28 SHEET 7 AA312 LEU C 64 PRO C 70 -1 O LEU C 66 N PHE C 57 SHEET 8 AA312 TRP G 5 VAL G 13 -1 O MET G 8 N GLN C 67 SHEET 9 AA312 GLN G 83 LYS G 91 -1 O VAL G 85 N TRP G 11 SHEET 10 AA312 ALA G 62 TYR G 69 -1 N THR G 67 O SER G 86 SHEET 11 AA312 ILE G 51 LEU G 59 -1 N SER G 52 O THR G 68 SHEET 12 AA312 PHE G 39 HIS G 42 -1 N ARG G 41 O GLU G 54 SHEET 1 AA4 7 TYR C 85 ASP C 87 0 SHEET 2 AA4 7 LYS C 94 LEU C 103 -1 O TYR C 96 N ASP C 87 SHEET 3 AA4 7 TYR G 94 GLN G 97 1 O GLN G 97 N ILE C 102 SHEET 4 AA4 7 GLN G 83 LYS G 91 -1 N LYS G 91 O TYR G 94 SHEET 5 AA4 7 ALA G 62 TYR G 69 -1 N THR G 67 O SER G 86 SHEET 6 AA4 7 ILE G 51 LEU G 59 -1 N SER G 52 O THR G 68 SHEET 7 AA4 7 PHE G 39 HIS G 42 -1 N ARG G 41 O GLU G 54 CISPEP 1 SER G 130 PRO G 131 0 1.99 CISPEP 2 LEU D 262 PRO D 263 0 -1.85 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000